Studies show everolimus-eluting stent implantation reduces restenosis and repeat revasculariztion

Two new studies have determined that everolimus-eluting stent implantation reduced the incidence of restenosis and repeat revascularization in patients with calcified culprit lesions, and had fewer clinical events. Details of both studies are published in the November issue of Catheterization and Cardiovascular Intervention, a peer-reviewed journal from the Society for Cardiovascular Angiography and Interventions.

Print PDF